These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23901156)

  • 1. Efficacy of Liposomal Monensin on the Enhancement of the Antitumour Activity of Liposomal Ricin in Human Epidermoid Carcinoma (KB) Cells.
    Tyagi N; Rathore SS; Ghosh PC
    Indian J Pharm Sci; 2013 Jan; 75(1):16-22. PubMed ID: 23901156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of surface charge and density of distearylphosphatidylethanolamine-mPEG-2000 (DSPE-mPEG-2000) on the cytotoxicity of liposome-entrapped ricin: effect of lysosomotropic agents.
    Rathore SS; Ghosh PC
    Int J Pharm; 2008 Feb; 350(1-2):79-94. PubMed ID: 17913409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced killing of human epidermoid carcinoma (KB) cells by treatment with ricin encapsulated into sterically stabilized liposomes in combination with monensin.
    Tyagi N; Rathore SS; Ghosh PC
    Drug Deliv; 2011 Aug; 18(6):394-404. PubMed ID: 21438723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate receptor mediated targeted delivery of ricin entrapped into sterically stabilized liposomes to human epidermoid carcinoma (KB) cells: effect of monensin intercalated into folate-tagged liposomes.
    Tyagi N; Ghosh PC
    Eur J Pharm Sci; 2011 Jul; 43(4):343-53. PubMed ID: 21621613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of ricin cytotoxicity by liposomal monensin under in vitro and in vivo conditions.
    Madan S; Vasandani VM; Ghosh PC
    Indian J Biochem Biophys; 1993 Dec; 30(6):405-10. PubMed ID: 8005625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the cytotoxicity of liposomal ricin by the carboxylic ionophore monensin and the lysosomotropic amine NH4Cl in Chinese hamster ovary cells.
    Bharadwaj S; Rathore SS; Ghosh PC
    Int J Toxicol; 2006; 25(5):349-59. PubMed ID: 16940007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monensin intercalation in liposomes: effect on cytotoxicities of ricin, Pseudomonas exotoxin A and diphtheria toxin in CHO cells.
    Madan S; Ghosh PC
    Biochim Biophys Acta; 1992 Sep; 1110(1):37-44. PubMed ID: 1390834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo potentiation of ricin toxicity by monensin delivered through liposomes.
    Vasandani VM; Madan S; Ghosh PC
    Biochim Biophys Acta; 1992 Jun; 1116(3):315-23. PubMed ID: 1377030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing potency of liposomal monensin on ricin cytotoxicity in mouse macrophage tumor cells.
    Madan S; Ghosh PC
    Biochem Int; 1992 Oct; 28(2):287-95. PubMed ID: 1456950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of antitumor immunotoxins by liposomal monensin.
    Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V
    J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P. berghei Infection in Murine Malaria.
    Rajendran V; Rohra S; Raza M; Hasan GM; Dutt S; Ghosh PC
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1304-18. PubMed ID: 26666937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stealth monensin immunoliposomes as potentiator of immunotoxins in vitro.
    Singh M; Ferdous AJ; Kanikkannan N; Faulkner G
    Eur J Pharm Biopharm; 2001 Jul; 52(1):13-20. PubMed ID: 11438419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of ricin A immunotoxin by monoclonal antibody targeted monensin containing small unilamellar vesicles.
    Singh M; Griffin T; Salimi A; Micetich RG; Atwal H
    Cancer Lett; 1994 Aug; 84(1):15-21. PubMed ID: 8076359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-circulating monensin nanoparticles for the potentiation of immunotoxin and anticancer drugs.
    Shaik MS; Ikediobi O; Turnage VD; McSween J; Kanikkannan N; Singh M
    J Pharm Pharmacol; 2001 May; 53(5):617-27. PubMed ID: 11370701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of monensin PLGA polymer nanoparticles and liposomes as potentiator of ricin A immunotoxins in vitro.
    Ferdous AJ; Stembridge NY; Singh M
    J Control Release; 1998 Jan; 50(1-3):71-8. PubMed ID: 9685874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cytotoxicity enhancers in combination with human serum on the activity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cells.
    van Horssen PJ; van Oosterhout YV; Evers S; Backus HH; van Oijen MG; Bongaerts R; de Witte T; Preijers FW
    Leukemia; 1999 Feb; 13(2):241-9. PubMed ID: 10025898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates.
    Candiani C; Franceschi A; Chignola R; Pasti M; Anselmi C; Benoni G; Tridente G; Colombatti M
    Cancer Res; 1992 Feb; 52(3):623-30. PubMed ID: 1732050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
    Griffin T; Raso V
    Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of monensin liposomes on the cytotoxicity of anti-My9-bR immunotoxin.
    Shaik MS; Jackson TL; Singh M
    J Pharm Pharmacol; 2003 Jun; 55(6):819-25. PubMed ID: 12841943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
    Kornfeld SB; Leonard JE; Mullen MD; Taetle R
    Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.